Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04664166 · ClinicalTrials.gov registry record
Alpena Otago Telehealth Program
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 23
- Enrollment target
NCT04664166: Completed study, sponsored by University of Michigan.
NCT04664166 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04664166 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
This project is to analyze the outcomes of the Alpena Otago Telehealth Program. The Alpena Senior Citizens Center is implementing the Otago program, an evidence-based, 6-month, home exercise program using live video chats in combination with an online exercise app, Blue Marble. We will recruit seniors who are participants of the Alpena Otago Telehealth Program to allow the study team to analyze their outcomes. The goal of the study is to examine the feasibility and efficacy of a 6-month, home-based, Otago Telehealth program for seniors in Alpena.
Primary Outcome
Number of participants completing the program
Interventions
- OTHER Alpena Otago Telehealth Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2021-12-04 |
What the finished NCT04664166 record still lists
NCT04664166 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Alpena Otago Telehealth Program is the first listed.
NCT04664166 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04664166 about?
NCT04664166 is a clinical study titled "Alpena Otago Telehealth Program". This project is to analyze the outcomes of the Alpena Otago Telehealth Program. The Alpena Senior Citizens Center is implementing the Otago program, an evidence-based, 6-month, home exercise program using live video chats in combination with an online exercise app, Blue Marble. We will recruit senio...
What is the current status of trial NCT04664166?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2021-02-01. Estimated completion is 2021-12-04.
What interventions are being tested in trial NCT04664166?
The interventions under investigation include: Alpena Otago Telehealth Program (OTHER).
Who is sponsoring clinical trial NCT04664166?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI